GLP-1 activity includes: Enhancing insulin secretion in a glucose-dependent manner Suppressing glucagon release, which would otherwise raise blood sugar Slowing gastric emptying to better regulate digestion Promoting satiety, which can reduce food intake GLP1-S in Research In laboratory research, GLP1-S is investigated for its ability to influence glucose homeostasis, appetite regulation, and energy balance
These effects are usually temporary and mild
As of late 2025/early 2026, retatrutide has not yet received full FDA approval
While GLP-1RAs can directly stimulate mTORC1 in some contexts, the net effect of the impaired mTOR signaling during sustained caloric deficit may favor catabolism [34]
we want to grow the lost hair back
GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Zepbound) have emerged as powerful tools for chronic weight management, but their use in patients with underactive thyroid requires careful medical evaluation